recent graduates
Stephen Slauson, Ph.D., 2009 Synthesis of Polymer-Supported(-)-Sparteine Derivatives
as External Chiral Ligands for Asymmetric Synthesis Dissertation director, Dr. John M. Rimoldi Current Position: Post-Doctoral Associate, Department of Medicinal Chemistry, University of Kansas (Prof. Jeff Aube)
Monica Love, Ph.D., 2009 Dissertation
director: Dr. John S. Williamson
Tuwanda Simmons, Ph.D., 2009 Dissertation
director: Dr. Mitchell A. Avery
Sanju Narayanan, Ph.D., 2009 Design, Synthesis and Biological Evaluation of Novel Selective Sigma-2 Receptor
Ligands Dissertation
director: Dr. Chris McCurdy Current Position: Research Scientist, Arena Pharmaceuticals, San Diego CA.
Prasanna Sivaprakasam, Ph.D., 2009 Targeting Signal Transduction Pathways: Farnesyltransferase and Glycogen Synthase Kinase-3 Inhibitors. Dissertation director, Dr. Robert Doerksen Current Position: Research Scientist, Bristol-Myers Squibb
Young B. Kim, Ph.D., 2008 Heteroatom Insertion Reaction of Metal Carbenoids: Synthesis and Biological Evaluation for Protein Kinase C. Dissertation director, Dr. John M. Rimoldi Current Position: Post-Doctoral Associate, Department of Chemistry, Texas A & M University (Prof. Brian Connell)
Jessica Adkins, Ph.D., 2008 Analytical Methodology for the Quantitation of Mitragynine and the Fingerprinting of Crude Extracts of Mitragyna speciosa.
Dissertation
director: Dr. Chris McCurdy Current Position: Post-Doctoral Research Associate, Office of Research & Sponsored Programs, University of Mississippi
David Weldon, Ph.D., 2008 The Design, Synthesis, and Biological Results of Novel Peptidomimetics for the Inhibition of Falcipain-2. Dissertation
director: Dr. Mitchell A. Avery Current Position: Assistant Professor, Loma Linda University School of Pharmacy, Loma Linda, CA.
Tiffany Clark, M.S., 2008 Development of Small-Molecule Inhibitors of Hypoxia Inducible Factor Activation through Pharmacophore Model Development. Thesis
director: Dr. Mitchell A. Avery Current Position:
Prasenjit Mukherjee, Ph.D., 2008 Use
of Molecular Modeling Tools in the Elucidation of Ligand Macromolecular
Interactions and Their Applications in Structure-Based Drug Design. Dissertation
director: Dr. Mitchell A. Avery Current Position: Research Scientist, Novartis
Anand Sridhar, Ph.D., 2008 Structure-Toxicity Relationship Studies of the Sesquiterpene Lactone Repin.
Dissertation director: Dr. John
M. Rimoldi Current Position: Post-Doctoral Associtate, Department of Medicinal Chemistry, University of Illinois, Chicago (Prof. Gregory Thatcher)
Nick Hammond, Ph.D., 2008
Isolation, Semi-synthesis, and Synthesis of Agents for Cancer, HIV, and Malaria.
Dissertation
director: Dr. Mitchell A. Avery Current Position: Chief Technology Officer, Ablitech, Inc.
Nakul Telang, Ph.D., 2007
Design, Synthesis, and Biological Evaluation of Isoflavones as Antigiardial
Agents.
Dissertation
director: Dr. Mitchell A. Avery Current Position:
Post-Doctoral Associate, University of Richmond.
Akshay Patny, Ph.D., 2007
Design, Molecular Modeling, and Biological Evaluation of Dual Activity Ligands
for Angiotensin II Receptor and Peroxisome Proliferator Activated Receptor
Gamma
Dissertation director: Dr. Mitchell A. Avery Current Position: Pfizer Global R & D, Structural & Computational Chemistry
Nidhi Singh, Ph.D., 2007
Part A: Protein Modeling in Rational Drug Design: Case Study
with Deoxyxylulose Phosphate Reductoisomerase Enzyme. Part B: Delineating
a Powerful Virtual Screening Approach for GPCRs: Application to Salvinorin
A, a Selective Kappa Opioid Receptor Agonist.
Dissertation
director: Dr. Chris McCurdy Current Position: Post-Doctoral Associate, Department of Chemistry, University of Southern California (Prof. Arieh Warshel)
Neha Vyas Philip, Ph.D., 2007
Design, Synthesis and Biological Evaluation
of Neuropeptide FF Receptor Ligands.
Dissertation
director: Dr. Chris McCurdy Current Position:
Seoung-Ryoung Choi, Ph.D., 2006 Design, Synthesis and Biological Evaluation of Inhibitors of Lactate
Dehydrogenase from Plasmodium falciparum.
Dissertation director: Dr. Mitchell
A. Avery Current Position: Post-Doctoral Associate, Department of Chemistry, University of Utah (Prof. C. Dale Poulter).
Cassia S. Mizuno, Ph.D., 2006
"Design and Synthesis of Novel Dual PPAR gamma Agonist/Angiotensin
II Antagonist for the Treatment of Type II Diabetes and Hypertension."
Dissertation director: Dr. Mitchell A. Avery Current Position: USDA ARS
Lindsay D. Odom, Ph.D., 2006 "Reactions of Diazoketones Catalyzed by Rhodium (II): Synthesis of Functionalized
Azetidines and Tetrahydrofurans as Potential Protein Kinase C Inhibitors." Dissertation director: Dr. John
M. Rimoldi Current Position: Research Associate, Core Synthesis Facilty, Department of Pharmaceutical and Biomedical Sciences,
University of South Carolina
Ashok
Philip, Ph.D., 2006 "Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel
NOP (nociceptin/orphanin FQ peptide) Receptor Ligands." Dissertation
director: Dr. Chris McCurdy Current Position: Assistant Professor, LECOM School of Pharmacy
Li Ze, Ph.D., 2006 "Rational Design, Synthesis of Nonsteroidal Antiprogestins."
Dissertation director: Dr. Mitchell A. Avery Current Position: Post-Doctoral Associate, Department of Medicinal Chemistry, University of Kansas Ginger P. Powe, Ph.D., 2003 "Chemical Modifications of Spiramycin I at the C-6 Ethyl Aldehyde Position."
Dissertation director: Dr. John S. Williamson Current Position: Assistant Professor & Coordinator, 2 + 2 Transfer Program Department of
Curriculum and Instruction, North Carolina A & T
State University
Maralea Gourley, Ph.D., 2003 "Design and Synthesis of Baterial Type 1 Signal Peptidase Inhibitors."
Dissertation director: Dr. John S. Williamson Current Position: Assistant Professor, Department of Chemistry, Henderson State University, Arkansas.
Mark S. Levi, Ph.D., 2002 "Ibogaine Analogs as Novel Agents for Addiction Therapy."
Dissertation director: Dr. Ronald F. Borne Current Position: Research Instructor of Pharm/Tox , University of Arkansas for Medicial Sciences.
Yogesh A. Sabnis, Ph.D., 2002 "Modeling, Design, and Synthesis of Parasitic Cysteine Protease Inhibitors."
Dissertation director: Dr. Mitchell A. Avery Current Position: Senior Scientist, Pfizer UK.
Tomoko Mineno, Ph.D., 2002 "Rational Design and Synthesis for the Discovery of Novel Antigiardial Agents."
Dissertation director: Dr. Mitchell A. Avery Current Position: Lecturer, Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.
Mingwei Chen, M.S., 2002 "Synthesis and Bioactivity of Erythromycin Derivatives."
Thesis director: Dr. John S. Williamson Current Position: Metabasis Therapeutics, San Diego, CA.
John Furr, Ph.D., 2002 "A Novel Method for 3D-QSAR Using Genetically Evolved Molecular Field Data and Artificial Neural Networks."
Dissertation director: Dr. Mitchell A. Avery Current Position: Computational Chemist, Ensemble Discovery, Boston, MA
Aaron B. Beeler, Ph.D., 2002 "Part
I: The Combanitorial Synthesis of a Novel Azetidine Library.
Part II: The Parallel Synthesis of a Novel Oxamic Acid
Libaray."
Dissertation director: Dr. John M. Rimoldi Current
Position: Research Assistant Professor & Assistant Director, Center for Chemical Methodology and
Library Development (CMLD), Department of Chemistry, Boston University.
Theresa Johnson, Ph.D., 2001 "Inhibition
of Lactate Dehydrogenase C4: The Design, Synthesis, and Testing
of Ligands as an Approach to Male Contraception."
Dissertation director: Dr. Mitchell A. Avery Current Position: Computational Chemist, Pfizer RTC, Biotherapeutics and Bioinnovation Center, Cambridge, MA
Hetal Mitra, M.S., 2001 "Rational Design and Synthesis of Helicobacter Pylori Urease Inhibitors."
Thesis director: Dr. John S. Williamson Current Position:
Maria A. Gaston, Ph.D., 2000 "Rational Design and Economic Synthesis of Orally Active Analogs of Artemesinin as Potential Antimalarials."
Dissertation director: Dr. Mitchell A. Avery Current Position: External Operations Consultant, Eli Lilly & Co., Indianapolis, IN
John Woolfrey, Ph.D., 2000 "Design and Synthesis of Potential Selective Progesterone Receptor Antagonists."
Dissertation director: Dr. Mitchell A. Avery Current Position: Computational Chemist, Exelexis, San Francisco, CA
|